Recent official advice has been published for healthcare practitioners involved in the COVID-19 vaccination programme by Public Health England which includes a specific section on the treatment for people with bleeding disorders (p15). It says,
Administering COVID-19 vaccine to individuals with a bleeding disorder
Individuals with bleeding disorders may be vaccinated intramuscularly if, in the opinion of a doctor familiar with the individual’s bleeding risk, vaccines or similar small volume intramuscular injections can be administered with reasonable safety by this route. If the individual receives medication/treatment to reduce bleeding, for example treatment for haemophilia, intramuscular vaccination can be scheduled shortly after such medication/treatment is administered. A fine needle (23 or 25 gauge) should be used for the vaccination, followed by firm pressure applied to the site (without rubbing) for at least 2 minutes (ACIP, 2019). The individual/carer should be informed about the risk of haematoma from the injection.
Haemophilia Scotland has checked with the Scottish Government and this advice is constant with advice in Scotland.
That means that the Government are indicating that people with bleeding disorders can have the vaccine but may need cover with a clotting product and should talk to the team treating them about risk from haematomas. As usual, we suggest anyone with concerns about how their bleeding disorder might impact their treatment should talk to their Haemophilia Centre.